Bellevue Asset Management »

Halozyme Therapeutics shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $5.5M 318k 17.33
2015-09-30 $3.3M 246k 13.43
2015-06-30 $2.1M 92k 22.58
2015-03-31 $1.3M 92k 14.28